Investor Seeks To Block DSM's $360M Kensey Nash Buyout

Law360, Wilmington (May 11, 2012, 3:52 PM EDT) -- A Kensey Nash Corp. shareholder on Wednesday launched a proposed class action in Delaware state court to block the medical device firm's $360 million merger with Dutch food and chemicals maker DSM NV.

Lead plaintiff Hilary Conye claims Kensey Nash’s agreed-upon sales price of $38.50 per share is "woefully inadequate" and is a product of a flawed process designed to ensure the sale of the company on preferential terms to DSM at the expense of shareholders.

"Kensey Nash represents a highly attractive acquisition candidate," the complaint...
To view the full article, register now.